Related Experiment Video
Updated: Sep 29, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Selenomethionine regulation of p53 by a ref1-dependent redox mechanism
Young R Seo1, Mark R Kelley, Martin L Smith
1Department of Microbiology, Walther Oncology Center, and Walther Cancer Institute, Indiana University School of Medicine, Indianapolis, IN 46208, USA.
Abstract:
The cancer chemopreventive properties of selenium compounds are well documented, yet little is known of the mechanism(s) by which these agents inhibit carcinogenesis. We show that selenium in the form of selenomethionine (SeMet) can activate the p53 tumor suppressor protein by a redox mechanism that requires the redox factor Ref1. Assays to measure direct reduction/oxidation of p53 showed a SeMet-dependent response that was blocked by a dominant-negative Ref1. By using a peptide containing only p53 cysteine residues 275 and 277, we demonstrate the importance of these residues in the SeMet-induced response. SeMet induced sequence-specific DNA binding and transactivation by p53. Finally, cellular responses to SeMet were determined in mouse embryo fibroblasts wild-type or null for p53 genes. The evidence suggests that the DNA repair branch of the p53 pathway was activated. The central relevance of DNA repair to cancer prevention is discussed.
Insights
Selenium (SeMet) activates the p53 tumor suppressor protein through a redox mechanism involving Ref1, enhancing DNA repair and cancer prevention. This study elucidates a key molecular pathway for selenium
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- The cancer chemopreventive effects of selenium compounds are recognized, but the underlying mechanisms remain largely unknown.
- Understanding how selenium inhibits carcinogenesis is crucial for developing effective cancer prevention strategies.
Purpose of the Study:
- To elucidate the mechanism by which selenomethionine (SeMet) activates the p53 tumor suppressor protein.
- To investigate the role of the redox factor Ref1 and specific p53 cysteine residues in SeMet-mediated p53 activation.
- To determine the cellular responses to SeMet, focusing on the DNA repair pathway.
Main Methods:
- Direct reduction/oxidation assays of p53.
- Use of dominant-negative Ref1 to block SeMet-induced responses.
- Peptide assays focusing on p53 cysteine residues 275 and 277.
- Measurement of SeMet-induced p53 DNA binding and transactivation.
- Analysis of cellular responses in p53 wild-type and null mouse embryo fibroblasts.
Main Results:
- Selenomethionine (SeMet) activates p53 via a redox mechanism dependent on the redox factor Ref1.
- Specific p53 cysteine residues (275 and 277) are critical for the SeMet-induced response.
- SeMet treatment leads to sequence-specific DNA binding and transactivation by p53.
- The DNA repair pathway of the p53 pathway was activated by SeMet in cellular assays.
Conclusions:
- Selenomethionine activates the p53 tumor suppressor protein through a redox mechanism involving Ref1 and specific cysteine residues.
- SeMet-induced p53 activation enhances DNA repair, suggesting a key role in cancer chemoprevention.
- These findings provide mechanistic insights into selenium's cancer-preventive properties.
Related Concept Videos
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Abnormal Proliferation
Negative Regulator Molecules
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Regulation of the Unfolded Protein Response

